|
|
| | CcpA-IN-1 Basic information |
| Product Name: | CcpA-IN-1 | | Synonyms: | CcpA-IN-1;Ruthenium(3+), bis[4,4′-bis(1,1-dimethylethyl)-2,2′-bipyridine-κN1,κN1′][[4-[4-(1H-imidazo[4,5-f][1,10]phenanthrolin-2-yl-κN7,κN8)phenoxy]butyl]triphenylphosphonium]-, (OC-6-21)-, hexafluorophosphate(1-) (1:3) | | CAS: | 2702277-62-9 | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![CcpA-IN-1 Structure]() |
| | CcpA-IN-1 Chemical Properties |
| | CcpA-IN-1 Usage And Synthesis |
| Uses | CcpA-IN-1 is a Staphylococcus aureus antibiotic. CcpA-IN-1 has significant bactericidal activity (MICS=460 nM)[1]. | | References | [1] Wang J, et al. Coupling a Virulence-Targeting Moiety with Ru-Based AMP Mimics Efficiently Improved Its Anti-Infective Potency and Therapeutic Index. J Med Chem. 2023 Sep 28;66(18):13304-13318. DOI:10.1021/acs.jmedchem.3c01282 |
| | CcpA-IN-1 Preparation Products And Raw materials |
|